Clinical TrialsSearch results
Number of results: 701
Other
- Cabozantinib ePRO study
- Renal cell carcinoma
- Osawa Takahiro
- 2021-12-06
Other
- Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
- Hypertension
- EBM Collaborating Research Center in Kyoto University
- 2005-10-30
Other
- CARDINALS
- amyotrophic lateral sclerosis
- Tansy Aaron
- 2023-10-12
Other
- Carotid-artery Intima irregurality as a risk factor for cardiovascular disease -observational prospective cohort study
- arterial sclerosis
- Nakajima clinic
- 2006-04-01
Other
- CHOP therapy for low and low-intermediate risk patients of advanced aggressive non-Hodgkin's lymphoma (JCOG9508, LSG17(CHOP))
- low and low-intermediate risk of aggressive non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-09
Other
- Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery (a randomized, double-blind, multi-center, placebo-controlled study)
- Colon cancer including RS cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery (a randomized, double-blind, multi-center, placebo-controlled study) Additional study:Gastrointestinal transit time as an indicator
- Colon cancer (Sigmoidal and Rectosigmoidal regions)
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-03-24
Other
- Clinical evaluation of matrix metalloproteinases as early diagnostic markers of peritoneal deterioration and encapsulating peritoneal sclerosis.
- encapsulating peritoneal sclerosis (EPS)/ sclerosing encapsulating peritonitis(SEP)
- Division of Nephrology, Department of Medicine, Jichi Medical University
- 2013-04-30
Other
- Clinical examination about immunoadsorption therapy for dilated cardiomyopathy
- dilated cardiomyopathy
- Department of Cardiology, Kitasato Institute Hospital
- 2007-03-01
Other
- Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancer
- colorectal cancer
- Tsukuba Cancer Clinical Trial Group
- 2008-12-03